{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-080268","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2024-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.376447+00:00","generated_at":"2026-05-31T03:46:22.607358+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Ilan Shiloah resigns from Silexion Therapeutics board effective Sept 16, 2024","bullets":["Ilan Shiloah resigned as independent director and from audit, compensation, and governance committees.","Resignation effective September 16, 2024; cited competing time demands.","No disagreement with company operations, policies, or practices stated.","Shiloah served since business combination closing on August 15, 2024.","No replacement named at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-080268","json":"https://secwatch.observer/filing/0001213900-24-080268.json","markdown":"https://secwatch.observer/filing/0001213900-24-080268.md","text":"https://secwatch.observer/filing/0001213900-24-080268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/0001213900-24-080268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/ea0215110-8k_silexion.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:46:22.607358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e9a5c14d1f","claim":"Ilan Shiloah resigned as independent director at Silexion Therapeutics Corp.","evidence_excerpt":"On September 16, 2024, Ilan Shiloah, an independent director serving on the board of directors (the “Board”) of Silexion Therapeutics Corp, a Cayman Islands exempted company (the “Company”), informed the Company that he has resigned from the Board, including from his membership on each of the committees of the Board— the audit committee, the compensation committee, and the corporate governance and nominating committee— effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2022416/000121390024080268/0001213900-24-080268-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}